In this webinar experts in ICD therapy will show how to increase the accurate and timely diagnosis of atrial fibrillation (AF) to improve AF patient outcomes.
Dr Mathias Busch (Greifswald, DE) will present the importance of detecting new onset AF in patients with a single chamber ICD. Dr Martin Martinek (Linz, AT) will show the efficacy of atrial antitachycardia pacing in reducing persistent AF in patients with a pacemaker, ICD or CRT device. The session will be moderated by Dr Mathias Meine (Utrecht, NL).
Dr Mathias Meine is a cardiologist in the Utrecht Medical Center in Utrecht, The Netherlands where he is responsible for ICD and pacemaker therapy. His research activities are focused on the prediction and treatment of tachyarrhythmias in heart failure patients and improving cardiac resynchronization therapy.
Dr Mathias Busch is deputy director of the department for cardiology, pneumology, angiology and medical intensive care since 2017 and head of the Rhythmology division since 2011 at the University Hospital of Greifswald, Germany. His professional focus is on interventional patient care (mainly electrophysiology, devices, structural heart) and physician education (e.g. EP fellowship program certified by German cardiac society).
Assoc Prof Martin Martinek is senior consultant for internal medicine, cardiology, angiology, and intensive care medicine. He is senior electrophysiologist and head of the department for device therapy at the Ordensklinikum Linz Elisabethinen and consultant for EP at the University Clinic of St. Pölten, Austria. His main scientific focus is on the ablation of atrial fibrillation and ventricular tachycardia, as well as device therapy.
This webinar aims to inform cardiologists, cardiac device implanters and allied healthcare professionals who are involved in the referral, implantation and/or follow-up of patients with ICDs on:
- AF as a growing disease, important as it may result in increased mortality, stroke and cardiac decompensation.
- Incidence of new onset detection atrial fibrillation and the importance of detecting this in patients with single chamber ICDs.
- How atrial antitachycardia pacing (Reactive ATP) works and reduces the incidence of persistent and/or permanent AF in patients with an implanted cardiac device.
- Cardiologists/electrophysiologists involved in the implantation and/or follow-up of ICDs.
- Allied healthcare professionals such as physiologists, hospital technicians or nurses involved in ICD therapies.
- Biffi M et al. Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation. Int J Cardiol. 2017 Mar 1;230:275-280.
- Boriani G, et al. Understanding the incidence of AF in single-chamber ICD patients: a real-world analysis. EP Europace 2017 (19), Issue suppl. 3, 1 June 2017, iii154.
- Boriani G. et al. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicenter international trial. Eur Heart J. 2014;35:2352–2362.
- Boriani G. et al. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. Heart Rhythm June 2015;12(6):1192-1200.
- Brown ML, et al. New AF Occurrence in Single-Chamber ICD Patients: Insights from a Real-World Investigation. Presentation at HRS congress 2018; B-PO03-040.
- Deshmukh A. et al. Performance of Atrial Fibrillation Detection in a New Single-Chamber ICD. Pacing Clin Electrophysiol. 2016 Oct;39(10):1031-1037.
This webinar is supported by: